Otsuka Pharmaceutical Factory and ICU Medical completed the formation of Otsuka ICU Medical for $200m.

Otsuka Pharmaceutical Factory, a global healthcare company, and ICU Medical, a company that provides medical devices and accessories, infusion therapy products, and critical care products, completed the formation of Otsuka ICU Medical, an IV solution business in North America joint venture, for $200m. Otsuka ICU Medical LLC aims to strengthen the supply system of IV solutions in North America by leveraging its strong production capabilities in the region, ICU Medical's distribution network, and the advanced technologies developed by Otsuka Pharmaceutical Factory, a leading company in IV solutions in Japan. The company seeks to contribute to the stable supply of IV solutions, enhance its IV solution business in North America, and promote technological innovation in its IV solution products, Otsuka statement.